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Abstract. 
 
Adherent cells assemble fibronectin into a 
fibrillar matrix on their apical surface. The fibril forma-
tion is initiated by fibronectin binding to the integrins 
 
a
 
5
 
b
 
1 and 
 
a
 
v
 
b
 
3, and is completed by a process that in-
cludes fibronectin self-assembly. We found that a 76–
amino acid fragment of fibronectin (III1-C) that forms 
one of the self-assembly sites caused disassembly of 
preformed fibronectin matrix without affecting cell ad-
hesion. Treating attached fibroblasts or endothelial 
cells with III1-C inhibited cell migration and prolifera-
tion. Rho-dependent stress fiber formation and Rho-
dependent focal contact protein phosphorylation were 
also inhibited, whereas Cdc42 was activated, leading to 
actin polymerization into filopodia. ACK (activated 
Cdc42-binding kinase) and p38 MAPK (mitogen-acti-
 
vated protein kinase), two downstream effectors of 
Cdc42, were activated, whereas PAK (p21-activated ki-
nase) and JNK/SAPK (c-Jun NH
 
2
 
-terminal kinase/
stress-activated protein kinase) were inhibited. III1-C 
treatment also modulated activation of JNK and ERK 
(extracellular signal-regulated kinases) in response to 
growth factors, and reduced the activity of the cyclin 
E–cdk2 complex. These results indicate that the ab-
sence of fibronectin matrix causes activation of Cdc42, 
and that fibronectin matrix is required for Rho activa-
tion and cell cycle progression.
Key words: extracellular matrix • signal transduction 
• F-actin • mitogen-activated protein kinase (MAPK) • 
cyclin E–cdk2
 
F
 
IBRONECTIN
 
 is a multifunctional component of the ex-
tracellular matrix. Intracellular signaling induced
by cell adhesion on fibronectin plays a critical role
in cytoskeletal organization, cell cycle progression, and
cell survival (Hynes, 1990; Frisch and Ruoslahti, 1997).
Cells assemble fibronectin into a fibrillar form that accu-
mulates at their apical surface. Fibronectin matrix forma-
tion is initiated by fibronectin binding to cell surface re-
ceptors, followed by assembly and reorganization of the
cell surface–associated fibronectin into fibrils (Mosher et
al., 1992; Mosher, 1993; McDonald, 1988). The 
 
a
 
5
 
b
 
1 inte-
grin is the major receptor responsible for fibronectin ma-
trix assembly (Ruoslahti, 1991; Wu et al., 1993). The 
 
a
 
v
 
b
 
3
integrin can also direct matrix assembly (Wennerberg et
al., 1996; Wu et al., 1996), which may account for fibronec-
tin matrix formation in 
 
a
 
5 integrin null mice (Yang et al.,
1993). A number of other integrins bind to fibronectin, but
do not initiate fibril formation (Busk et al., 1992; Zhang et
al., 1993; Wu et al., 1995
 
a
 
). The first type III repeat of the
fibronectin molecule is important in promoting matrix as-
sembly (Morla and Ruoslahti, 1992; Aguirre et al., 1994;
Hocking et al., 1994). Small fragments derived from this
III1 module induce fibronectin polymerization at moder-
ate concentrations, but inhibit it at high concentrations
(Morla and Ruoslahti, 1992; Morla et al., 1994).
Interaction of integrins with the actin cytoskeleton is
also essential for matrix assembly (Hynes, 1990). Trunca-
tion of the 
 
b
 
1 cytoplasmic domain blocks fibronectin ma-
trix assembly by preventing the interaction of the ligand-
occupied integrin with the cytoskeleton (Wu et al., 1995
 
b
 
).
Formation of polymerized actin structures and assembly
of associated integrin complexes are controlled by the Rho
family of small GTPases: Rho, Rac, and Cdc42 (Hall,
1998). In Swiss 3T3 cells, activation of Rho leads to forma-
tion of actin stress fibers and focal adhesion complexes
(Kumagai et al., 1993; Rankin et al., 1994; Seufferlein and
Rozengurt, 1994), whereas Rac activation induces assem-
bly of an actin meshwork at the cell periphery producing
lamellipodia and membrane ruffles (Hotchin and Hall,
1995; Nobes and Hall, 1995). Cdc42 activation causes
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filopodial protrusions at the cell periphery. A close cor-
relation exists between actin stress fiber formation and
fibronectin matrix assembly. Thus, disrupting the cytoskel-
eton with cytochalasin D inhibits fibronectin matrix as-
sembly, whereas lysophosphatidic acid (LPA)
 
1
 
, which in-
duces stress fiber formation, enhances it (Zhang et al.,
1994). Inhibiting Rho with C3 transferase inhibits the
LPA-induced matrix assembly (Zhang et al., 1997), sug-
gesting that LPA acts through Rho to increase fibronectin
binding at the cell surface. Moreover, fibronectin fibrils
coalign with bundles of actin filaments and with focal ad-
hesion-like sites that lack vinculin or talin. These structures
are different from the punctate focal adhesion involved in
the cell–substratum interaction (Chen and Singer, 1982;
Chen et al., 1985). This specialization suggests that fibronec-
tin matrix may activate integrin-linked intracellular signal-
ing pathways and cytoskeletal reorganization in ways that
are different from those at canonical focal adhesions.
Here we study the role of the fibronectin matrix in cy-
toskeletal regulation by disassembling the fibronectin ma-
trix with a 76–amino acid fragment derived from the first
type III repeat of fibronectin (Morla and Ruoslahti, 1992;
Morla et al., 1994), or by preventing matrix assembly with
integrin antibodies. Cell adhesion is not discernibly af-
fected by the III1-C fragment, allowing us to separate the
effects of surface matrix disruption from adhesion to a
substrate. Removing the fibronectin matrix from the cell
surface disrupts the stress fibers and focal contacts, and re-
organizes the cytoskeleton into filopodia at the cell periph-
ery, suggesting inactivation of Rho and activation of Cdc42.
We also show that III1-C treatment affects growth factor
pathways and reduces the activity of the cyclin E–cdk2
complex, thereby impeding the progression of cell cycle.
 
Materials and Methods
 
Cell Culture
 
Primary cultures of human umbilical vein endothelial cells (HUVECs)
were purchased from Clonetics (San Diego, CA) and grown in M199 me-
dium supplemented with 20% FCS, 10 ng/ml bFGF, 10 ng/ml EGF, and 1
 
m
 
g/ml heparin. HUVECs were used between passages 2 and 8. Normal
human KD fibroblasts were grown in minimum essential medium
(
 
a
 
MEM) supplemented with 10% FCS.
 
Antibodies
 
Anti-paxillin, FAK, and phosphotyrosine (PY20) antibodies were pur-
chased from Transduction Laboratories (Lexington, KY); phosphospe-
cific antibodies for p38 MAPK and p44/42 MAPK were purchased from
New England Biolabs (Beverly, MA); anti-JNK1 was purchased from
PharMingen (San Diego, CA); antibodies against Cdc42, ACK, PAK
 
a
 
,
PAK
 
g
 
,
 
 cdk2, cyclin E, ERK1, ERK2, and p38 MAPK were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA); anti-
 
a
 
5 blocking anti-
body (P1D6) was purchased from Calbiochem-Novabiochem Corp. (La
Jolla, CA); anti-
 
a
 
v
 
b
 
3 blocking antibody (LM609) was purchased from
Chemicon International, Inc. (Temecula, CA); anti-
 
b
 
1 blocking antibody
(P4C10) was purchased from Telios Pharmaceuticals (San Diego, CA);
and the anti-fibronectin antibody was generated in our laboratory (Zhang
et al., 1993).
 
Expression and Purification of Recombinant Proteins
 
III1-C and III-11C (III-CF) fibronectin fragments were expressed in
 
Escherichia coli
 
 as histidine-tail fusion proteins, and were purified by
metal-chelate affinity chromatography on nickel-agarose beads (Ni-NTA
superflow; QIAGEN Inc., Valencia, CA) as previously described (Morla
et al., 1994). Purified proteins were dialyzed against TBS and concen-
trated by centrifugation using Centricon-10 (Amicon Corp., Easton, TX).
Purity of protein preparations was verified on Coomassie blue–stained
SDS-PAGE gels.
 
Immunofluorescence Microscopy
 
Cells were grown to confluence on Lab-Tek 4-well chamber slides (Nunc,
Inc., Naperville, IL) in complete medium, washed once in serum-free me-
dium, and incubated in the absence or presence of III1-C for the indicated
time. When indicated, the cells were treated for the final 15 min with 5 
 
m
 
M
lysophosphatidic acid (LPA; Sigma Chemical Co., St Louis, MO). The
cells were fixed in 4% paraformaldehyde in PBS for 30 min, permeabi-
lized in 0.2% Triton X-100 in PBS, treated with PBS containing 0.5%
BSA, and incubated for 1 h with the primary antibodies diluted in the
PBS/BSA solution. FITC or rhodamine-coupled secondary antibodies
(Sigma Chemical Co.) were used for detection. Actin cytoskeleton was
stained with rhodamin–phalloidin (Molecular Probes, Inc., Eugene, Ore-
gon).
 
Fluorescence Assays for Fibronectin Fibril Formation
 
KD fibroblasts were starved for 24 h, trypsinized to remove their existing
fibronectin matrix, and resuspended in serum-free medium containing 100
 
m
 
g/ml soybean trypsin inhibitor (Sigma Chemical Co.). Cells were washed
once in serum-free medium and seeded onto Lab-Tek 4-well chamber
slides that had been precoated with a mixture of 10 
 
m
 
g/ml collagen type IV
(Sigma Chemical Co.) and 10 
 
m
 
g/ml vitronectin purified from human
plasma as described (Yatohgo et al., 1988). Cells were allowed to attach
and spread for 1–6 h before fixation for immunostaining. In some experi-
ments, the cells were allowed to attach and spread for 1 h on the matrices
before adding inhibitory anti-integrin antibodies. The cells were incubated
for an additional 6 h before fixing and staining for surface fibronectin or
actin cytoskeleton. The antibodies did not prevent adhesion to or cause
detachment from the mixed matrices. In similar experiments, HUVECs,
which do not express collagen integrins, were plated on substrates coated
with a mixture of 10 
 
m
 
g/ml fibronectin (Boehringer Mannheim Corp., In-
dianapolis, IN) and 10 
 
m
 
g/ml laminin (Sigma Chemical Co.) and grown in
complete medium for 2 d before adding integrin-blocking antibodies for
4 h in serum-free medium. Because fibronectin was one of the substrates,
we were only able to stain for actin in these cells.
 
DNA Replication Assay
 
Cells were plated in 96-well plates and incubated with the indicated
amounts of III1-C in complete medium. After 48 h, HUVEC proliferation
was assessed by an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide) incorporation assay. The cells were incubated with 300
 
m
 
g/ml MTT for 6 h. After overnight extraction with 10% SDS in 0.01 N
HCl, the OD was read at 590 nm.
 
Immunoprecipitation and Immunoblotting
 
The cells were lysed in an NP-40 based buffer (0.1% NP-40, 50 mM Tris-
HCl, pH 7.4, 250 mM NaCl, 5 mM EDTA) containing protease inhibitors
(1 mM PMSF, 10 
 
m
 
g/ml leupeptin, 0.1 U/ml aprotinin, 0.4 
 
m
 
g/ml pepstatin)
and the phosphatase inhibitor Na
 
3
 
VO
 
4
 
 (1 mM). The insoluble fraction was
removed by centrifugation, and the cleared lysates were used for immuno-
precipitation with antibodies to FAK and paxillin. ACK immunoprecipi-
tation was performed as previously described (Satoh et al., 1996) in 50
mM Hepes, pH 7.3, 150 mM NaCl, 10% glycerol, 1% NP40, 2 mM MgCl
 
2
 
,
1 mM EDTA, 20 mM glycero-phosphate, 10 mM pyrophosphate, and pro-
tease and phosphatase inhibitors. Proteins were separated by SDS-PAGE,
transferred to Immobilon-P membranes (Millipore Corp., Bedford, MA),
blotted with an anti-phosphotyrosine antibody, and visualized with chemi-
luminescence substrate (NEN™ Life Science Products, Boston, MA).
 
Kinase Assays
 
Kinase assays for ERK2 and JNK1 were performed as described previ-
ously (Cavigelli et al., 1995). In brief, cells were lysed on ice in an NP-40
based lysis buffer (50 mM Hepes, pH 7.6, 250 mM NaCl, 3 mM EDTA, 3
mM EGTA, 0.5% NP-40) containing protease and phosphatase inhibitors.
 
1. 
 
Abbreviations used in this paper
 
: HUVEC, human umbilical vein endo-
thelial cells; LPA, lysophosphatidic acid. 
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ERK2 or JNK1 were immunoprecipitated using appropriate antibodies
and protein A-Sepharose beads (Pharmacia Biotech Sverige, Uppsala,
Sweden). For the ERK2 kinase assays, PHAS-1 (Stratagene, La Jolla,
CA) was used as the substrate at 5 
 
m
 
g/reaction. GST-c-Jun (1–79) was
used as the substrate for the JNK1 kinase assays at 5 
 
m
 
g/reaction. Kinase
reactions containing the immunoprecipitated kinase, substrate, 10 
 
m
 
M
ATP, and 5 
 
m
 
Ci [
 
g
 
-
 
32
 
P] ATP in the kinase buffer (50 mM Hepes, pH 7.6,
10 mM MgCl
 
2
 
) were incubated at room temperature for 30 min before
separation by SDS-PAGE.
For p38 MAP kinase, cells were lysed on ice in a Triton X-100 based ly-
sis buffer (20 mM Tris-HCl, pH 8, 137 mM NaCl, 2 mM EDTA, 1% Triton
X-100, 10% glycerol, 25 mM glycerophosphate, 2 mM pyrophosphate)
containing protease and phosphatase inhibitors as described (Raingeaud
et al., 1995). p38 MAPK was immunoprecipitated with the anti-p38 anti-
body that was preadsorbed to protein-A Sepharose for 30 min. The kinase
reaction was performed at 30
 
8
 
C for 30 min in presence of ATF-2 (Santa
Cruz Biotechnology, Santa Cruz, CA) as the substrate at 5 
 
m
 
g/reaction, 10
 
m
 
M ATP, and 5 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP in the kinase buffer (25 mM Hepes, pH
7.6, 25 mM MgCl
 
2
 
, 25 mM glycerophosphate, 2 mM DTT, 0.1 mM
Na
 
3
 
VO
 
4
 
).
PAK
 
a
 
 and PAK
 
g
 
 kinase assays were performed as described (La-
marche et al., 1996). Cells were lysed in 50 mM Tris-HCl, pH 8, 150 mM
NaCl, 1 mM EDTA, 0.1% Triton X-100, 1 mM PMSF, 10 
 
m
 
g/ml leupeptin,
0.1 U/ml aprotinin, 0.4 
 
m
 
g/ml pepstatin, and 1 mM Na
 
3
 
VO
 
4
 
. The kinase ac-
tivity of the PAK immunoprecipitates was analyzed by incubating at 30
 
8
 
C
for 30 min with MBP (Sigma Chemical Co.) as substrate at 5 
 
m
 
g/reaction,
40 
 
m
 
M ATP, and 5 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP in the kinase buffer (20 mM Tris-HCl,
pH 7.5, 20 mM MgCl
 
2, 
 
 10 mM MnCl
 
2
 
, 1 mM EDTA, 1 mM EGTA).
Cyclin E–cdk2 complex kinase assays were performed as described
(Fang et al., 1996). In brief, HUVECs were synchronized by serum starva-
tion in 
 
a
 
MEM supplemented with bovine insulin (5 
 
m
 
g/ml), transferrin (5
 
m
 
g/ml), and sodium selenite (5 ng/ml) for 24 h (Fang et al., 1996). Serum-
starved cells (
 
z
 
70% confluent) were incubated with the indicated amount
of fibronectin and III-1C in complete medium. After 18 h, cells were lysed
in 0.1% NP-40 buffer (50 mM Tris-HCl, pH 7.4, 5 mM NaF, 250 mM
NaCl, 5 mM EDTA, 0.1% NP-40, 15 
 
m
 
g/ml benzamidine, 10 
 
m
 
g/ml trypsin
inhibitor, 10 
 
m
 
g/ml leupeptin, 4 
 
m
 
g/ml pepstatin, 0.1 U/ml aprotinin). 50
 
m
 
g of protein were immunoprecipitated with 2–3 
 
m
 
g of antibody pread-
sorbed to protein A-Sepharose or protein G-Sepharose (Pharmacia Bio-
tech Sverige) in 0.1% NP-40 buffer. The kinase activity of cyclin E–cdk2
was determined by in vitro phosphorylation of the histone H1 substrate at
100 
 
m
 
g/reaction in kinase buffer (100 mM Tris-HCl, pH 7.5, 10 mM MgCl
 
2
 
,
1 mM DTT, 100 
 
m
 
M) for 30 min at room temperature.
All reactions were stopped by adding electrophoresis sample buffer,
and proteins were separated on 4–20% SDS-PAGE (Novex, San Diego,
CA). Kinase activity was detected by autoradiography (BioMAX MR;
Eastman Kodak Co., Rochester, NY) and quantified by scanning the au-
toradiographs with a flatbed scanner (Hewlett-Packard Co., Palo Alto,
CA) and analyzing them with NIH Image 1.57.
 
Plasmids and Transfections
 
Dominant negative forms of Cdc42 (Cdc42N17), Rac (RacN17), and the
constitutively active forms of Rho (RhoV14) and Rac (RacV12) were gifts
from Dr. Alan Hall. The pE-GFP plasmid was from QIAGEN Inc. (Va-
lencia, CA).
One day before transfection, HUVECs were seeded onto Lab-Tek
4-well chamber slides (Nunc, Inc.) at 5 
 
3 
 
10
 
4
 
 cells per well in complete
medium. Cells were then transfected with 0.2 
 
m
 
g pE-GFP alone, or were
cotransfected with 1 
 
m
 
g of the indicated plasmid, by using the Superfect
reagent (QIAGEN Inc.) according to the manufacturer’s protocols. After
24 h, the cells were treated with III1-C for 4 h in serum-free medium,
fixed, and stained with rhodamine-phalloidin as described above.
 
Results
 
Cells Treated with Fibronectin Fragment III1-C Lose 
Fibronectin Matrix
 
Fragments from the first type III repeat of fibronectin
have been shown to promote fibronectin matrix assembly
at low concentrations, and to inhibit it at high concentra-
tions (Morla and Ruoslahti, 1992; Morla et al., 1994). We
found that high concentrations of III1-C can also disrupt
an established fibronectin matrix. Adding the fibronectin
III1-C fragment for 4 h to HUVEC or for 16 h to KD fi-
broblast cultures in serum-free medium caused complete
loss of the fibronectin fibrils on the cell apical surface that
were detectable by immunostaining of fibronectin (Fig. 1
 
A
 
). Despite this, the cells remained attached to the culture
dish. A fragment derived from the eleventh type III fi-
bronectin repeat (III-CF) that is analogous to III1-C and
that has been used previously as a negative control for
III1-C (Morla et al., 1994) had no effect on the fibronectin
matrix.
The effect of III1-C on fibronectin matrix was dose-
Figure 1. Treatment with III1-C removes surface fibronectin ma-
trix. Immunofluorescence staining of fibronectin: (A, top) on the
surface of HUVECs with or without treatment with 20 mM III1-C
or with 20 mM of the control fragment III-CF for 4 h in serum-
free medium, or (A, bottom) on the surface KD fibroblasts after
treatment with or without 20 mM III1-C for 16 h in serum-free
medium; (B) on the surface of KD fibroblasts treated with the in-
dicated concentrations of III1-C for 16 h; (C) in Triton X-100–
permeabilized KD fibroblasts after treatment for 16 h with 20 mM
III1-C in serum free-medium or with the medium alone. 
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dependent: low concentrations of III1-C (between 0.1 and
1 
 
m
 
M) increased accumulation of fibronectin matrix at the
cell surface, higher III1-C concentrations (2.5–10 
 
m
 
M) de-
creased fibronectin matrix, and at 20 
 
m
 
M the matrix was
undetectable by immunofluorescence staining (Fig. 1 
 
B
 
).
Removing fibronectin matrix by 20 
 
m
 
M III1-C required
several hours. The time course varied depending on the
cell type (2–3 h for HUVEC; 4–6 h for KD fibroblasts; not
shown), but seemed to depend on the amount of fibronec-
tin matrix that had previously accumulated on the cell sur-
face. The effect of III1-C was reversible; after removing
surface fibronectin with 20 
 
m
 
M III1-C, the KD fibroblasts
maintained in serum-free medium that did not contain
III1-C regenerated their fibronectin matrix within 24 h. In-
creased intracellular fibronectin staining was seen in the
III1-C–treated KD fibroblasts after permeabilization with
Triton X-100 (Fig. 1 
 
C
 
). These results show that III1-C dis-
assembles fibronectin fibrils and causes intracellular accu-
mulation of fibronectin, but does not affect cell substrate
adhesion.
 
Fibronectin Matrix Removal Inhibits Cell Migration 
and Proliferation
 
As cell substrate adhesion was not discernibly affected by
III1-C treatment, we were able to assess the cellular ef-
fects of disrupting surface fibronectin matrix without per-
tubing cell attachment or spreading. Treating CHO cells
with high concentrations of III1-C (10–50 
 
m
 
M) has been
shown to inhibit their migration in an in vitro wound assay
(Morla et al., 1994). HUVECs and KD fibroblasts re-
sponded similarly: cell migration assessed by wound assay
was inhibited by III1-C in proportion with the reduction of
cell surface fibronectin matrix. High concentrations of
III1-C also inhibited cell proliferation as measured by an
MTT assay, whereas low concentrations enhanced fi-
bronectin deposition and cell proliferation (results not
shown). These initial findings encouraged us to use the
III1-C treatment to study the effects of fibronectin matrix
on various signaling pathways.
 
Fibronectin Matrix is Required for Rho-mediated 
Formation of Stress Fibers and Phosphorylation of 
Focal Adhesion Proteins
 
Because a strong correlation exists between organization
of actin stress fibers and assembly of fibronectin matrix
(Zhang et al., 1994; Zhang et al., 1997), we tested whether
fibronectin matrix removal by III1-C would affect cyto-
skeletal organization. HUVECs and KD fibroblasts
treated with 20 
 
m
 
M III1-C in serum-free medium redistrib-
uted their filamentous actin into filopodia (Fig. 2). The
control fragment III-CF had no effect on the cytoskeleton
(not shown). Moreover, the Rho-dependent induction of
stress fibers by LPA was prevented by the III1-C treat-
ment (Fig. 3), and the III1-C–induced disruption of stress
fibers could be obliterated by transfecting cells with a con-
stitutively active form of Rho (result not shown). The cy-
toskeletal changes correlated with the ability of III1-C to
remove cell surface fibronectin matrix; treating the cells
with 20 
 
m
 
M III1-C for 15 min, which was not long enough
Figure 2. III1-C treatment stimulates formation of filopodial pro-
trusions of the cytoskeleton at the cell periphery. Rhodamine-
phalloidin staining of the actin cytoskeleton (top) in KD fibro-
blasts after treatment with or without 20 mM III1-C for 16 h in
serum free medium; (bottom) in HUVECs with or without treat-
ment with 20 mM III1-C for 4 h in serum-free medium. The im-
ages were produced with a confocal microscope.
Figure 3. Fibronectin matrix removal blocks Rho-mediated
stress fiber formation. Rhodamine-phalloidin staining of the actin
cytoskeleton. HUVECs were treated in serum-free medium in
the absence (medium, top) or presence of 20 mM III1-C for 4 h
(middle) or 20 mM III1-C for the last 15 min. The cells were then
stimulated (right) or left unstimulated (left) with 5 mM LPA for
15 min. The images were produced with a confocal microscope.Bourdoulous et al. Signaling Through Fibronectin Matrix 271
to remove the matrix, did not prevent the cytoskeletal re-
sponses to LPA.
III1-C also only slightly reduced the tyrosine phosphor-
ylation of FAK and paxillin in attached cells, prevented
the increase in FAK and paxillin phosphorylation elicited
by LPA and essentially eliminated the association of FAK
and paxillin with one another (Fig. 4 A). These effects
were seen only when cells were treated long enough to re-
move cell surface fibronectin matrix; a 15-min treatment
had no effect. Moreover, cells treated with III1-C in sus-
pension before attachment onto various substrates at-
tached equally well as untreated cells and phosphorylated
FAK and paxillin to the same extent (Fig. 4 B). These re-
sults suggest that Rho-pathways are inhibited in the III1-C
treated cells, and that assembling a fibronectin matrix
rather than adhering to a substrate, is necessary for cells to
initiate Rho-dependent actin stress fiber formation. Sub-
strate adherence seems to elicit most of the focal adhesion
protein phosphorylation, but FAK-paxillin association is
controlled by the matrix.
To explore further the dependence of actin organization
on the presence of cell surface fibronectin, we removed
the fibronectin matrix from KD fibroblasts by trypsiniza-
tion, plated them onto integrin ligands other than fi-
bronectin—a mixture of collagen IV and vitronectin—and
observed accumulation of the fibronectin matrix and the
assembly of the actin cytoskeleton at different time points.
While integrin-mediated cell adhesion and spreading oc-
curred rapidly (in 15–30 min), fibronectin matrix assembly
required several hours (Fig. 5 A). This time course was
similar to that required for the cells to form stress fibers
(Fig. 5 B).
Figure 4. Fibronectin matrix removal blocks Rho-mediated ty-
rosine phosphorylation of focal contact proteins FAK and paxil-
lin. (A) HUVECs were treated for 4 h with 20 mM III1-C in se-
rum-free medium to remove fibronectin matrix (1) or with the
medium alone (2). Where indicated, LPA cells were stimulated
with 5 mM LPA for 15 min before lysis. As a control for the ef-
fects of III1-C without removing fibronectin matrix, 20 mM III1-C
was added for 15 min in absence (III1-C) or presence of 5 mM
LPA (III1-C 1 LPA). FAK or paxillin were immunoprecipitated
and immunoblotted with an anti-phosphotyrosine antibody
(PY20). The blots were reprobed with anti-FAK or anti-paxillin
antibodies to show that similar protein levels were immunopre-
cipitated and to detect FAK that had coimmunoprecipitated with
paxillin. (B) Suspended HUVECs were treated for 1 h with (1)
or without (2) 20 mM III1-C in serum-free medium before plat-
ing on dishes coated with 10 mg/ml fibronectin, vitronectin, or
laminin. The cells were lysed after 30 min, and FAK or paxillin
was immunoprecipitated and immunoblotted with an anti-phos-
photyrosine antibody (PY20). The experiments were carried out
three to five times, and a representative result is shown.
Figure 5. Time course of fibronectin matrix deposition and stress
fiber organization after attachment of cells on substrate.
Trypsinized KD fibroblasts were plated on a mixture of collagen
IV and vitronectin in serum-free medium and stained after 1,  2,
4, or 6 h for cell surface fibronectin (A) or actin cytoskeleton (B).The Journal of Cell Biology, Volume 143, 1998 272
We also used antibodies to prevent accumulation of sur-
face fibronectin matrix. Integrins, particularly a5b1, and
to a some extent, avb3 direct fibronectin matrix assembly.
We tested whether blocking these integrins would have a
similar effect on the actin cytoskeletal organization as
III1-C. We allowed KD fibroblasts or endothelial cells to
attach and spread on a mixture of collagen and vitronectin
or laminin and fibronectin, and then added blocking anti-
bodies directed against the a5b1 and avb3 integrins indi-
vidually or in combination. Because fibroblasts and endo-
thelial cells can use integrins other than a5b1 and avb3 to
adhere to collagen IV, vitronectin, and laminin, these anti-
bodies did not prevent adhesion and spreading on the sub-
strate. When added individually, both the b1-blocking an-
tibody (P4C10) and the avb3-blocking antibody (LM609)
reduced fibronectin matrix assembly in the fibroblasts;
P4C10 was more efficient than LM609 (Fig. 6 A). Adding
both these antibodies together prevented fibronectin
matrix accumulation (Fig. 6 A) and reduced stress fiber or-
ganization (Fig. 6 B). HUVECs plated on a mixture of
laminin and fibronectin and treated with both of the anti-
integrin antibodies underwent the same changes as the fi-
broblasts. They also displayed filopodial protrusions at the
cell periphery (Fig. 6 C), similar to those observed in the
III1-C-treated cells; however, III1-C was more efficient in
both removing fibronectin matrix and inducing filopodia.
Thus, it seems that fibronectin matrix assembly, and not
cell adhesion per se, is essential for proper stress fiber or-
ganization.
Fibronectin Matrix Removal Activates Cdc42 and 
ACK1 but not PAK1
Formation of filopodial protrusions at the cell periphery
suggests that Cdc42 may be activated in the III1-C–treated
cells. To analyze the involvement of Cdc42, HUVECs
were transfected with a dominant-negative form of Cdc42
(Cdc42N17) before treatment with III1-C. Cdc42N17 ex-
pression did not affect cytoskeletal organization of stress
fibers in control cells, but completely blocked formation of
the peripheral filopodia in III1-C-treated cells (Fig. 7),
thus indicating that Cdc42 mediates the cytoskeletal reor-
ganization in cells depleted of fibronectin matrix. In con-
trast, expression of a dominant negative form of Rac
(RacN17) had no effect on the III1-C–induced filopodia
(not shown).
To develop additional evidence for Cdc42 activation in
the III1-C treated cells, we analyzed whether ACK was ac-
tivated by fibronectin removal. ACK1 and 2 are nonrecep-
tor tyrosine kinases that bind to and are activated by
Cdc42 (Manser et al., 1993; Yang and Cerione, 1997). A
marked enhancement of ACK1 tyrosine phosphorylation
was seen in KD fibroblasts treated with III1-C long
enough (16 h) to remove fibronectin matrix (Fig. 8 A). A
weaker but consistent induction of ACK tyrosine phos-
phorylation was observed in HUVECs treated with III1-C
for 4 h. In contrast, a 15-min treatment with III1-C did not
alter ACK1 tyrosine phosphorylation. Hyperosmotic shock
and a decrease in temperature, both of which have been
shown to activate ACK1 (Satoh et al., 1996), also in-
creased ACK1 phosphorylation. Activation of ACK1 fur-
ther suggests that Cdc42 is activated in cells depleted of fi-
bronectin matrix.
We next tested whether PAK was activated in III1-C
treated cells. PAK is a serine/threonine kinase that can be
activated in vitro by GTP-bound Cdc42 or Rac (Manser et
al., 1995; Manser et al., 1994). Moreover, PAK is a known
regulator of JNK/SAPK and p38 MAPK (Retta et al.,
1998), and may mediate activation of JNK by Rac and
Cdc42 (Joneson et al., 1996; Lamarche et al., 1996; Tang et
al., 1997). Surprisingly, we found that basal kinase activity
Figure 6. Inhibition of fibronectin matrix assembly with function-
blocking integrin antibodies prevents stress fiber formation.
Trypsinized KD fibroblasts were plated on a mixture of collagen
IV and vitronectin in serum-free medium. The cells were allowed
to attach and spread for 1 h before adding function-blocking anti-
bodies directed against the b1 (P4C10, 10 mg/ml) or avb3
(LM609, 10 mg/ml) integrins individually or in combination. Af-
ter an additional 6 h, the cells were stained for cell surface fi-
bronectin (A) or actin cytoskeleton (B). (C) HUVECs were
grown on a mixture of fibronectin and laminin in complete me-
dium for 48 h, and were then treated with the function-blocking
antibodies directed against the a5 (P1D6, 10 mg/ml) or avb3
(LM609, 10 mg/ml) integrins individually or in combination in se-
rum-free medium. The cells were stained after 4 h for actin cy-
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of PAK1 (Fig. 8 B) and PAK2 (not shown) was decreased
in III1-C–treated HUVECs. Moreover, III1-C pretreatment
attenuated activation of PAK1 by anisomycin or growth
factors (bFGF and EGF), suggesting that fibronectin ma-
trix removal inhibits a signaling cascade leading to PAK.
Fibronectin Matrix Removal Causes Activation of p38 
MAPK but not JNK or ERK1/2
Cdc42 is known to stimulate a kinase cascade that leads to
subsequent activation of the p38 MAPK and JNK/SAPK
but not the MAPK ERK1/2 (Coso et al., 1995; Minden et
al., 1995). To test whether the activation of Cdc42 in III1-
C–treated cells correlates with the activation of these ki-
nases, we examined the activity of p38 MAPK and JNK.
p38 MAPK is activated by dual phosphorylation on ty-
rosine and threonine residues in cells subjected to various
types of stress (Raingeaud et al., 1995). p38 MAPK be-
came phosphorylated in HUVECs treated with III1-C to
remove fibronectin matrix (Fig. 9 A). Stimulation with
LPA or EGF, but not bFGF, also caused p38 MAPK phos-
phorylation. Stimulation with III1-C together with LPA or
EGF had little or no additive effect, indicating that III1-C
alone maximally activated p38 MAPK (Fig. 9 A). A 15-
min treatment of HUVECs with III1-C did not induce p38
MAPK phosphorylation, again suggesting that the p38
MAPK activation relates to the loss of fibronectin matrix
rather than stimulation by III1-C itself. p38 MAPK activa-
tion in the III1-C–treated cells was further confirmed by
using an in vitro kinase assay. The stimulation by III1-C
was nearly as strong as that of anisomycin, a known activa-
tor of p38 MAPK (Fig. 9 B).
Even though JNK can be activated by Cdc42 and Rac
(Coso et al., 1995; Minden et al., 1995), basal kinase activ-
ity and growth factor–induced activity of JNK were inhib-
ited in III1-C–treated cells (not shown). Movever, integrin-
mediated adhesion is an activator of ERK1 and ERK2
Figure 7. Expression of a dominant nega-
tive form of Cdc42 prevents the formation
of III1-C–induced filopodia. HUVECs
cells were transfected GFP alone, or with
GFP and Cdc42N17 before treatment with
20 mM III1-C for 4 h in serum-free me-
dium and stained for actin cytoskeleton
(top). In the lower panel, the same cells
were analyzed for GFP expression to iden-
tify the transfected cells.
Figure 8. Tyrosine phosphorylation of ACK and inhibition of
PAK1 kinase activity in response to fibronectin matrix removal
by III1-C. (A) Tyrosine phosphorylation of ACK: KD fibroblasts
were treated with 20 mM III1-C for 16 h. HUVECs were treated
with 20 mM III1-C for 4 h or 15 min, or were stimulated by hyper-
osmotic shock (0.8 M NaCl for 10 min) or by decreasing the tem-
perature (258C for 30 min). Serum-free medium was used as a
control (medium). ACK was immunoprecipitated and immuno-
blotted with an anti-phosphotyrosine antibody (PY20). (B)
PAK1 in vitro kinase assay using MBP as the substrate. HUVECs
were pretreated with 20 mM III1-C for 4 h in serum-free medium
to remove fibronectin matrix (1), or were treated with the me-
dium alone (2), and where indicated, were stimulated by aniso-
mycin (10 mg/ml), bFGF (10 ng/ml), or EGF (10 ng/ml) for 5 min
before lysis. This experiment was carried out four times with sim-
ilar results, and representative results are shown. (C) Controls
confirmed that an equivalent amount of PAK protein was immu-
noprecipitated from the III1-C treated and control cells.The Journal of Cell Biology, Volume 143, 1998 274
(Chen et al., 1994; Schlaepfer et al., 1994), III1-C had only
minor effects on the activation of these kinases and did not
affect their expression at the protein level (results not
shown).
Fibronectin Matrix Removal Inhibits Cell Proliferation 
by Inactivating Cyclin E–cdk2 Kinase
Preventing adhesion to an extracellular matrix blocks cell
cycle progression by suppressing the activities of cyclin/cy-
clin-dependent kinase (cdk) complexes such as the cyclin
E–cdk2 complex (Fang et al., 1996). We found that cyclin
E–cdk2 activity was also completely blocked in HUVECs
and in KD fibroblasts treated with III1-C (Fig. 10 and re-
sults not shown). The activity of the cyclin D-cdk4 com-
plex, which acts before the cyclin E–cdk2 complex in the
cell cycle, was not reduced in cells treated with III1-C (not
shown). These results suggest that assembling fibronectin
matrix is necessary for proliferation of attached cells and
that matrix depletion blocks the cell cycle at the level of
cyclin E–cdk2.
Discussion
We show here that disrupting fibronectin matrix causes cy-
toskeletal reorganization by activating the small GTPase
Cdc42, alters growth factor signaling, and blocks cell cycle
progression.
We were able to remove the fibronectin matrix by using
a small protein fragment derived from the III1-C module
of fibronectin. At low concentrations, this fragment pro-
motes fibronectin matrix assembly, but prevents it at high
concentrations (Morla and Ruoslahti, 1992; Morla et al.,
1994). Furthermore, as we show here, high concentrations
of III1-C can disassemble an already formed fibronectin
matrix.
Several lines of evidence indicate that the alterations in
signaling caused by III1-C treatment are caused by remov-
ing fibronectin from the apical surface of attached cells
rather than by alterations in cell-substrate adhesion, cell
shape, or by some other action of the peptide. First, fi-
bronectin does not accumulate at the basal cell surface
(Chen and Singer, 1980; Chen and Singer, 1982), making it
unlikely that III1-C would exerts its effect at the site of
substrate adhesion. In agreement with this, III1-C did not
block adhesion of cells to surfaces coated with extracellu-
lar matrix proteins, nor did it change cell shape. Second, as
discussed in detail later, we found the cellular changes in-
duced by III1-C to be quite different from those induced
by detachment from substrate, Third, treatment of cells
with III1-C for short periods of time did not cause the
same effect as matrix removal obtained with prolonged
exposure of cells to III1-C; the alterations in signaling
and cytoskeletal organization always correlated with the
amount of surface fibronectin present. Finally, we show
that blocking fibronectin matrix assembly with antiinte-
grin antibodies, while not affecting cell attachment, caused
cytoskeletal reorganization similar to that produced by
III1-C treatment.
We found that cell growth parallels accumulation of sur-
face fibronectin matrix, and that removal of the matrix
prevents growth. Similarly, others have shown that inhibit-
ing of fibronectin matrix assembly in various ways inhibits
cell growth (Mercurius and Morla, 1998; Saulnier et al.,
1996). Thus, cell proliferation appears to require a fi-
bronectin matrix, at least in normal cells.
Our results show that actin stress fiber organization in
spread cells also depends on fibronectin matrix. We found
that fibronectin matrix assembly preceded stress fiber for-
mation in attached and spread cells. Moreover, fibronectin
matrix removal induced by III1-C or inhibitory integrin
antibodies suppressed Rho-dependent stress fiber organi-
zation and Rho-dependent tyrosine phosphorylation of fo-
cal adhesion proteins. These results indicate that activat-
ing Rho GTPase requires the presence of a fibronectin
matrix. Rho activity, in turn, promotes fibronectin matrix
assembly, and this effect requires an intact cytoskeleton
(Zhang et al., 1994; Chrzanowska-Wodnicka and Bur-
ridge, 1996; Zhang et al., 1997).
Fibronectin matrix depletion by III1-C treatment, while
inhibiting Rho functions, seems to activate the related GTP-
Figure 9. Fibronectin matrix removal activates p38 MAPK. (A)
Immunoblotting with a phosphospecific (Tyr182) p38 antibody or
conventional p38 antibody. HUVECs were pretreated (1) with
20 mM III1-C for 4 h in serum-free medium to remove fibronectin
matrix, or were left untreated (2). Where indicated, the cells
were then stimulated with 5 mM LPA for 15 min before lysis
(LPA). As a control, HUVECs were treated with 20 mM III1-C
for the final 15 min in the absence (III1-C) or the presence of 5
mM LPA (III1-C 1 LPA). Alternatively, cells were stimulated
with 10 ng/ml EGF or bFGF for 15 min before lysis. Treatment
with serum-free medium was used as a control (Medium) in both
experiments. (B) P38 MAPK in vitro kinase assay using ATF-2 as
substrate. HUVECs were treated (1) with 20 mM III1-C for 4 h
and, where indicated, were stimulated with bFGF (10 ng/ml) or
anisomycin (10 mg/ml) for 15 min or left untreated in serum-free
medium (2) and then lysed.
Figure 10. Fibronectin matrix
removal inhibits the activity of
the cyclin E–cdk2 complex. Syn-
chronized HUVECs and KD fi-
broblasts were treated with 10
mM III1-C or 10 mg/ml fibronec-
tin (FN) as a control for 18 h in complete medium. Cdk2 was im-
munoprecipitated and in vitro kinase assays for the cyclin E–cdk2
complex were performed using histone-1 as the substrate. In vitro
kinase assays were also performed on lysates that were immuno-
precipitated with an unrelated antibody as a control (Control).Bourdoulous et al. Signaling Through Fibronectin Matrix 275
ase Cdc42, as III1-C–treated cells showed the hallmark of
Cdc42 activity, formation of filopodia. Perturbing the fi-
bronectin matrix of HUVECs with anti-a5b1 and avb3
antibodies showed the same signs of Cdc42 activation, al-
beit at a lower level. The appearance of filopodia in the
III1-C–treated cells was caused by Cdc42 because it could
be inhibited by transfecting a dominant negative Cdc42
into the cells.
In most situations, Cdc42, Rac, and Rho are activated
sequentially in cells. Thus, formation of filopodia caused
by Cdc42 activation is accompanied by the appearance of
lamellipodia in cells that contain functional Rac. This is
followed by Rho-dependent organization of actin stress fi-
bers (Nobes and Hall, 1995). Our III1-C–treated cells have
activated Cdc42, but Rho is inactive. The studies that re-
vealed the existence of the sequential Cdc42/Rac/Rho
pathway were done under conditions that would allow fi-
bronectin matrix assembly. Thus, the lack of the Rho acti-
vation that would be expected from the earlier results is
likely to be due to the absence of fibronectin matrix in the
III1-C–treated cells. The increased Cdc42 activity in the
cells lacking fibronectin matrix is consistent with their un-
impaired attachment properties, as cell-substrate attach-
ment has been shown to increase Cdc42 activity (Price et
al., 1998).
Cdc42 and Rac activate JNK and p38 MAPK and,
through these kinases, regulate gene transcription (Coso
et al., 1995; Minden et al., 1995). However, most studies
exploring the effects of the Rho GTPases on the MAP ki-
nases have been performed by expressing mutant forms of
these proteins. Because III1-C treatment makes it possible
to activate Cdc42, and because it can be achieved without
activating Rac or Rho, we were able to study the down-
stream signaling pathways specifically regulated by en-
dogenous Cdc42. We found that one of the previously
identified Cdc42-dependent pathways was activated in the
III1-C–treated cells; there was increased tyrosine phos-
phorylation of ACK1, a protein that interacts with the ac-
tive form of Cdc42 (Manser et al., 1993). In contrast,
PAK1, a potent regulator of both JNK and p38 MAPK
that is known to interact not only with active Cdc42, but
also with active Rac (Manser et al., 1993), was inhibited in
III1-C–treated cells. Downstream activation of JNK was
also prevented by III1-C treatment, whereas p38 MAPK
was activated. These data suggest that Cdc42 may not di-
rectly activate PAK or JNK. Because Rac seems to be in-
hibited in III1-C–treated cells, Cdc42 may require Rac to
activate the JNK pathway, and activation of PAK and
JNK in cells expressing a constitutively active form of
Cdc42 may be caused by subsequent activation of Rac.
Consistent with this idea, JNK activation by Cdc42 can be
blocked by dominant negative Rac (Minden et al., 1995).
However, both JNK and ERK activation by anisomycin
were also inhibited in III1-C–treated cells (not shown).
Anisomycin is an inhibitor of protein synthesis commonly
used in MAPK activation studies, and it is thought to acti-
vate JNK independently of Cdc42 or Rac (Coso et al., 1995).
Therefore, it seems likely that a pathway that does not in-
volve the Rho-related proteins can activate JNK, and that
this pathway also requires an intact fibronectin matrix.
Detachment of epithelial and endothelial cells from the
extracellular matrix leads to programmed cell death; this
process is called anoikis (Frisch and Ruoslahti, 1997). JNK
is rapidly activated in detached cells; however, its role in
induction of apoptosis in these cells is still not clear (Frisch
et al., 1996; Khwaja and Downward, 1997). p38 MAPK is
also stimulated by detachment from the matrix (Khwaja
and Downward, 1997). In contrast, detachment suppresses
ERK and the growth factor–mediated activation of ERK
requires cell attachment (Renshaw et al., 1997). Interest-
ingly, we found that removal of fibronectin matrix without
altering the cell-substrate adhesion of the cells decreased
the basal activity of ERK while slightly potentiating ERK
response to growth factors. This effect and the activation
of P38 MAPK and suppression of JNK in III1-C–treated
cells show that the effects of matrix removal on MAPKs
are quite different from those of loss of substrate adhe-
sion. In agreement with this, depleting fibronectin matrix
had little effect on cell survival (not shown), while inhibit-
ing cell proliferation. Thus, signals from fibronectin matrix
seem to control cell proliferation, whereas cell substrate
adhesion provides a survival signal. These signals can be
modulated separately by removing the matrix or by allow-
ing cells to attach to a substrate in the absence of matrix.
A profound block of cyclin E–cdk2 activity occurred in
III1-C–treated cells, apparently accounting for the re-
duced cell proliferation. These results indicate that fi-
bronectin matrix is required for activation of cyclin E–cdk2
in anchorage-dependent cells. The growth-promoting ef-
fects of substrate adhesion requires cytoskeletal organiza-
tion (Assoian and Zhu, 1997), which is dependent on Rho
activity. Moreover, Rac as well as Rho is necessary for the
G1/S transition of the cell cycle (Olson et al., 1995; Hall,
1998). In contrast, Cdc42 can inhibit cell cycle progression
in G1 through a mechanism that requires p38 MAPK acti-
vation (Molnar et al., 1997). Thus, fibronectin matrix re-
moval may be blocking cell cycle progression by activating
Cdc42, and through it p38 MAPK, while inhibiting Rac
and Rho activation by Cdc42.
In summary, our results reveal a specialized role for cell
surface fibronectin matrix in cytoskeletal organization,
growth factor responses, and cell cycle control that cannot
be substituted for by cell adhesion to a substrate.
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